Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about INNPF
Recent news which mentions INNPF
This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations
April 04, 2025
Tickers
AAWH
AYRWF
CGC
GRAM
Tags
MRMD
IMCC
SHFS
From
Benzinga
Cannabinoid Leader Innocan Pharma's Q3: 174% YoY Revenue Growth
November 21, 2024
Tickers
INNPF
NEWS
Tags
News
INNPF
BI Sky Global
From
Benzinga
CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark
May 28, 2024
Tickers
AMZN
CBD
INNO
INNO
Tags
INNO
Roni Kamhi
Cannabis
From
Benzinga
This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain
April 23, 2024
Tickers
INNO
INNO
INNPF
NEWS
Tags
CSE:INNO
Joseph Pergolizzi
Benzinga
From
Benzinga
534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations
April 02, 2024
Tickers
CBD
INNO
INNO
INNPF
Tags
Benzinga
Iris Bincovich
CSE:INNO
From
Benzinga
CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval
February 13, 2024
Tickers
CBD
INNO
INNO
INNPF
Tags
Earnings
Cannabis Earnings
Benzinga
From
Benzinga
Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
December 22, 2023
Tickers
CFO
EEX
INNO
INNO
Tags
Miriam McDonald
Wes Getman
Indigenous Cannabis Industry Association
From
Benzinga
More Cannabis Funding For FDA And Product Expansion: How This Pharma Tech Company Is Doing It
October 23, 2023
Tickers
INNPF
Tags
Private Placement
Offerings
Market News
From
Benzinga
CBD-Focused Pharma Co. Seeks Funding To Revolutionize Healthcare
September 21, 2023
Tickers
CBD
INNPF
Tags
Cannabis Funding
finanicng
Market News
From
Benzinga
Innocan Pharma's Q2 2023 Reports Gross Profit Growth Driven By Robust Subsidiary Sales
August 28, 2023
Tickers
INNPF
Tags
Iris Bincovich
Retail Sales
Benzinga
From
Benzinga
Cannabis Stock Gainers And Losers From August 25, 2023
August 25, 2023
Tickers
ACB
ACRHF
AGFY
AKAN
Tags
SKYE
ETST
CNPOF
From
Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
August 21, 2023
Tickers
ACRDF
ACRHF
AKAN
AYRWF
Tags
MGCLF
UGRO
GRUSF
From
Benzinga
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
August 17, 2023
Tickers
AAWH
ACRDF
ACRHF
AGFY
Tags
Benzinga
CXXIF
ACRDF
From
Benzinga
Cannabis Stock Gainers And Losers From August 14, 2023
August 14, 2023
Tickers
ACRHF
AGFY
AKAN
BBRRF
Tags
INNPF
RDDTF
SNDL
From
Benzinga
Cannabis Stock Gainers And Losers From August 11, 2023
August 11, 2023
Tickers
AAWH
ACRHF
AGFY
ALID
Tags
CXXIF
GBHPF
Benzinga
From
Benzinga
Innocan Pharma Secures $1.4M Via Private Placement
August 04, 2023
Tickers
INNPF
Tags
Benzinga
premium
Penny Stocks
From
Benzinga
Innocan Pharma To Secure Up To $3M Via Private Placement Of Units At A 9% Prime Above Share Price
July 25, 2023
Tickers
INNPF
Tags
Markets
Cannabis
Market News
From
Benzinga
Cannabis Stock Movers For July 21, 2023
July 21, 2023
Tickers
ACB
ALID
AYRWF
BBRRF
Tags
CNGGF
CXXIF
Benzinga
From
Benzinga
Innocan Pharma Q1 Revenue Grows 500%, Here Is What You Need To Know
June 01, 2023
Tickers
INNPF
Tags
Cannabis
Markets
Market News
From
Benzinga
Innocan Pharma FY22 Revenue Grows 1205% To $2.6M, Here Is What You Need To Know
April 19, 2023
Tickers
INNPF
Tags
Cannabis
Markets
Earnings
From
Benzinga
Can Liposomal CBD Injection Help Dogs With Polyarthritis? Innocan Pharma Reports Clinical Success
February 21, 2023
Tickers
INNPF
Tags
Markets
Cannabis
Market News
From
Benzinga
Innocan Pharma Q3 Revenue Grows 700% YoY, Here Is What You Need To Know
November 29, 2022
Tickers
INNPF
Tags
Markets
Cannabis
Market News
From
Benzinga
4 CBD Stocks in the Canadian Capital Market
November 02, 2021
Tickers
INNPF
Tags
Opinion
Guest Post
Penny Stocks
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.